LOCALLY ADVANCED HER2 POSITIVE BREAST CARCINOMA

Clinical trials for LOCALLY ADVANCED HER2 POSITIVE BREAST CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new LOCALLY ADVANCED HER2 POSITIVE BREAST CARCINOMA trials appear

Sign up with your email to follow new studies for LOCALLY ADVANCED HER2 POSITIVE BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

New drug cocktail tested for Tough-to-Treat breast cancer

Disease control Terminated

This study tested a combination of three drugs—trastuzumab, tucatinib, and vinorelbine—for people with advanced HER2-positive breast cancer that cannot be removed by surgery or has spread. The goal was to see if this combination could shrink tumors and control the disease for peo…

Matched conditions: LOCALLY ADVANCED HER2 POSITIVE BREAST CARCINOMA

Phase: PHASE2 • Sponsor: Spanish Breast Cancer Research Group • Aim: Disease control

Last updated Mar 17, 2026 13:09 UTC

LOCALLY ADVANCED HER2 POSITIVE BREAST CARCINOMA

Get alerted when new LOCALLY ADVANCED HER2 POSITIVE BREAST CARCINOMA trials appear

New drug cocktail tested for Tough-to-Treat breast cancer